ArticleBreast cancer (Tokyo, Japan)2025
Digitally quantified area of residual tumor after neoadjuvant chemotherapy in HER2-positive breast cancer.
Mao Uematsu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it